Cyclopentolate Hydrochloride
Code | Size | Price |
---|
TAR-T8383-10mg | 10mg | £96.00 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here. |
Quantity:
TAR-T8383-1mL | 1 mL * 10 mM (in DMSO) | £99.00 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here. |
Quantity:
TAR-T8383-25mg | 25mg | £124.00 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here. |
Quantity:
TAR-T8383-50mg | 50mg | £148.00 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here. |
Quantity:
TAR-T8383-100mg | 100mg | £210.00 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here. |
Quantity:
Prices exclude any Taxes / VAT
Overview
Regulatory Status: RUO
Shipping:
cool pack
Storage:
-20℃
Images
Documents
Further Information
Bioactivity:
Cyclopentolate Hydrochloride is a muscarinic acetylcholine receptors antagonist with Kis of 1.62, 27.5, and 2.63 nM for M1, M2, and M3 receptors, respectively.
CAS:
5870-29-1
Formula:
C17H26ClNO3
Molecular Weight:
327.85
Pathway:
Neuroscience
Purity:
0.9828
SMILES:
Cl.CN(C)CCOC(=O)C(c1ccccc1)C1(O)CCCC1
Target:
AChR
References
Ishikawa H , Desantis L , Patil P N . Selectivity of Muscarinic Agonists Including (?)-Aceclidine and Antimuscarinics on the Human Intraocular Muscles[J]. Journal of Ocular Pharmacology & Therapeutics, 1998, 14(4):363-373.
Akemi Wakayama.et al.Incidence of Side Effects of Topical Atropine Sulfate and Cyclopentolate Hydrochloride for Cycloplegia in Japanese Children: A Multicenter Study.Multicenter Study Jpn J Ophthalmol. 2018 Sep;62(5):531-536.